Transcriptional and post-translational regulatory system for hypoxia specific gene expression using the erythropoietin enhancer and the oxygen-dependent degradation domain
- 28 August 2007
- journal article
- research article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 121 (3), 218-224
- https://doi.org/10.1016/j.jconrel.2007.05.036
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3′-untranslated region for the VEGF gene therapyJournal of Controlled Release, 2006
- Hypoxia-Regulated Expression of Attenuated Diphtheria Toxin A Fused with Hypoxia-Inducible Factor-1α Oxygen-Dependent Degradation Domain Preferentially Induces Apoptosis of Hypoxic Cells in Solid TumorCancer Research, 2005
- 193. Hypoxia-Inducible VEGF Gene Therapy Using the RTP801 PromoterMolecular Therapy, 2004
- Protection From Ischemic Heart Injury by a Vigilant Heme Oxygenase-1 Plasmid SystemHypertension, 2004
- Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functionsExperimental & Molecular Medicine, 2004
- Hypoxia-Inducible Factor-1 Mediates Activation of Cultured Vascular Endothelial Cells by Inducing Multiple Angiogenic FactorsCirculation Research, 2003
- Angiogenesis of the heartMicroscopy Research and Technique, 2003
- Adenovirus-Mediated Bcl-XL Expression Using a Neuron-Specific Synapsin-1 Promoter Protects against Disseminated Neuronal Injury and Brain Infarction Following Focal Cerebral Ischemia in MiceNeurobiology of Disease, 2002
- Hypoxia-inducible transgene expression in differentiated human NT2N neurons – a cell culture model for gene therapy of postischemic neuronal lossGene Therapy, 2001
- Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.JCI Insight, 1994